| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/12/2005 | CA2544786A1 Method for producing gene transferred dendritic cells |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543528A1 Placental stem cells and uses thereof |
| 05/12/2005 | CA2542904A1 Iap nucleobase oligomers and oligomeric complexes and uses thereof |
| 05/12/2005 | CA2542884A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent |
| 05/12/2005 | CA2542875A1 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells |
| 05/12/2005 | CA2542874A1 Compositions of stabilized dna for coating microprojections |
| 05/12/2005 | CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 05/12/2005 | CA2538695A1 Clq related protein |
| 05/11/2005 | EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 05/11/2005 | EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 05/11/2005 | EP1529106A1 Modified tailed oligonucleotides |
| 05/11/2005 | EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 05/11/2005 | EP1529064A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 05/11/2005 | EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1250430B1 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 05/11/2005 | EP1214416B1 Use of replication-deficient adenoviral vector in the manufacture of a medicament to boost cd8+ t cell immune response to antigen |
| 05/11/2005 | EP1105738B1 Assays for modulating nuclear localisation |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0575350B1 Methods for the ex-vivo replication and stable genetic transformation of human stem cells |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615316A Novel immunogenic mimetics of multimer proteins |
| 05/11/2005 | CN1615157A Compositions inhibiting rejection in organ transplantation and method of using the same |
| 05/11/2005 | CN1615151A Plasmid mediated suplementation for treating chronically ill subjects |
| 05/11/2005 | CN1615150A Assay for the detection of factors that modulate the expression of INGAP |
| 05/11/2005 | CN1615140A Polynucleotide therapy |
| 05/11/2005 | CN1614027A Polytheneimine transgened carrier of targeted fibroblast growth factor receptor |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1201003C Adipocyte-specific protein homologs |
| 05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6890908 Modified ribozymes |
| 05/10/2005 | US6890897 In combination with an osteoinductive protein and a bone morphogenetic protein or a hedgehog protein to induce osteogenesis; biocompatible or biodegradable matrix |
| 05/10/2005 | US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/10/2005 | US6890743 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses |
| 05/10/2005 | US6890733 MEKK1 (serine threonine kinases)-interacting FHA (forkhead associated domain) protein 1 (M1F1) |
| 05/10/2005 | US6890728 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components |
| 05/10/2005 | US6890721 For treating Alzheimer's/Parkinson's disease/rheumatoid arthritis/sepsis/stroke/inflammation/ischemia/cardiovascular/ liver disease/multiple sclerosis/acquired immune deficiency syndrome(AIDS)/male pattern baldness/tumors/cancer |
| 05/10/2005 | US6890709 For induction of S-phase/oncogenicity/transcription/apoptosis in cells |
| 05/10/2005 | US6890557 A film forming emulsions comprising triglycerides, cholesterol, phospholipids, an charged lipid, and water; drug delivery with an apoprotein, deliverying nucleic acid, a gene therapy |
| 05/10/2005 | US6890554 Genetic immunization with cationic lipids |
| 05/10/2005 | US6890538 Immunization against herpes simplex virus |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | US6890528 Cells for the production of helper dependent adenoviral vectors |
| 05/10/2005 | US6890339 Stent lining |
| 05/10/2005 | CA2067330C Herpes simplex virus type 1 mutant |
| 05/06/2005 | WO2005040391A1 Compositions and methods for differentiating stem cells |
| 05/06/2005 | WO2005040387A1 Site-specific intestinal delivery and/or production of biologically active substances |
| 05/06/2005 | WO2005040383A1 B lymphoid lineage specific promoter sequences and pharmaceutical compositions containing the same |
| 05/06/2005 | WO2005040356A2 Mutant p53 protein and uses thereof |
| 05/06/2005 | WO2005040351A2 Compositions for inducing cell growth and differentiation and methods of using same |
| 05/06/2005 | WO2005040347A2 Methods and compositions for inhibiting cell growth and proliferation |
| 05/06/2005 | WO2005040340A2 Rnai-based modification of heterochromatin |
| 05/06/2005 | WO2005040333A2 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | WO2005040219A1 Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| 05/06/2005 | WO2005040213A1 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES |
| 05/06/2005 | WO2005040188A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | WO2005040187A2 The use of sirna silencing in the prevention of metastasis |
| 05/06/2005 | WO2005039645A2 Sp1 and sp3 targeted cancer therapies and therapeutics |
| 05/06/2005 | WO2005039644A1 Method of transferring soluble interferon ϝ receptor gene and composition for preventing or treating arteriosclerosis |
| 05/06/2005 | WO2005039643A2 In vivo gene therapy of parkinson's disease |
| 05/06/2005 | WO2005039642A1 Dna delivery with gemini cationic surfactants |
| 05/06/2005 | WO2005039615A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
| 05/06/2005 | WO2005002607A3 Oncolytic reoviruses for the treatment of neoplasms having activated pp2a or rac |
| 05/06/2005 | WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 05/06/2005 | WO2004112825A3 Combinations of tumor-associated antigens for the treatment of various types of cancers |
| 05/06/2005 | WO2004080418A3 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 05/06/2005 | WO2004047727A3 Compositions and methods for diagnosing and treating mood disorders |
| 05/06/2005 | WO2004041889A3 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/06/2005 | WO2003062394A3 Methods and compositions for rna interference |
| 05/06/2005 | WO2003057840A3 Compositions for dna mediated gene silencing |
| 05/06/2005 | WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/06/2005 | WO2002095007A3 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 05/06/2005 | WO2002072787A3 Telomerase expression repressor proteins and methods of using the same |
| 05/06/2005 | CA2543565A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
| 05/06/2005 | CA2543200A1 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | CA2543189A1 In vivo gene therapy of parkinson's disease |
| 05/06/2005 | CA2542924A1 Msp-3-like family of genes |
| 05/06/2005 | CA2542708A1 Dna delivery with gemini cationic surfactants |
| 05/06/2005 | CA2541280A1 Modified cdna for high expression levels of factor viii and its derivatives |
| 05/06/2005 | CA2540023A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | CA2536078A1 Rnai-based modification of heterochromatin |
| 05/06/2005 | CA2534996A1 The use of sirna silencing in the prevention of metastasis |
| 05/06/2005 | CA2532094A1 Sp1 and sp3 targeted cancer therapies and therapeutics |
| 05/05/2005 | US20050096460 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 05/05/2005 | US20050096289 Methods and compositions for modulating tissue factor |
| 05/05/2005 | US20050096288 Antigen specific immune response by providing low density lipoprotein and a nucleic acid to be expressed as antigen bonded to each other for genes in vaccines |
| 05/05/2005 | US20050096287 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin a solution in water |
| 05/05/2005 | US20050096286 Plasmid encoding of fibroblast growth factor as treatment for hypercholesterolemia or diabetes |
| 05/05/2005 | US20050096285 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 05/05/2005 | US20050096277 Methods of prevention and treatment using apolipoprotein analogues |
| 05/05/2005 | US20050096273 Regulation of matrix metalloproteinases by PSP94 family members |
| 05/05/2005 | US20050095710 Antisense modulation of PTP1B expression |
| 05/05/2005 | US20050095709 Compositions and methods for inhibiting translation of a chimeric gene |
| 05/05/2005 | US20050095704 Using nuclear transplantaion to transfer preferential nuclear material into enucleated animal oocyte; tissue engineering; gene therapy |
| 05/05/2005 | US20050095681 Intracellular modulators of apoptopic cell death pathways |